ImmunityBio's recently approved cancer drug has plenty of momentum. However, valuation concerns and clinical and regulatory ...

Professor David Kerr examines a massive meta-analysis raising questions about GLP-1 drugs and colorectal cancer risk in ...

The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social ...

Immune checkpoint inhibitors targeting PD-1 and PD-L1 have revolutionized cancer therapy, delivering long-term survival benefits in several malignancies. However, nearly half of patients show limited ...

Over a five-year span, women who used complementary and alternative medicine had a greater mortality rate than those who ...

Researchers from Yale University School of Medicine have now found that those who undergo CAM have over three times higher risk of death than those who receive standard therapy. Using CAM alongside st ...

Nature Medicine starts an investigation into inconsistencies in a study that found it was better to have immunotherapy in the morning.

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

H2Ocean proudly participated in the 4th International Conference on Cancer Health Disparities (ICCHD) & 9th Annual ...

Doctors at Northwestern Medicine said nearly 80% of lung cancer cases aren't discovered until they've reached advanced stages. They say by lowering the age of when to get screened for lung cancer more ...

Researchers from the Johns Hopkins Kimmel Cancer Center and The Johns Hopkins University have created a novel database structure that allows investigators anywhere to more easily ...